Polymorphisms in circadian genes, night work and breast cancer: Results from the GENICA study

References

• Allebrandt KV, Roenneberg T. (2008). The search for circadian clock components in humans: New perspectives for association studies. Braz J Med Biol Res. 41:716–21
   PubMed Web of Science ®Google Scholar
• Archer SN, Laing EE, Möller-Levet CS, et al. (2014). Mistimed sleep disrupts circadian regulation of the human transcriptome. Proc Natl Acad Sci U.S.A. 111:E682–91
   PubMed Web of Science ®Google Scholar
• Blask DE, Hill SM, Dauchy RT, et al. (2011). Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J Pineal Res. 51:259–69
   PubMed Web of Science ®Google Scholar
• Brown SA, Kunz D, Dumas A, et al. (2008). Molecular insights into human daily behavior. Proc Natl Acad Sci U.S.A. 105:1602–7
   PubMed Web of Science ®Google Scholar
• Calle ML, Urrea V, Vellalta G, et al. (2008). Improving strategies for detecting genetic patterns of disease susceptibility in association studies. Stat Med. 27:6532–46
   PubMed Web of Science ®Google Scholar
• Cos S, Sánchez-Barceló EJ. (2000). Melatonin and mammary pathological growth. Front Neuroendocrinol. 21:133–70
   PubMed Web of Science ®Google Scholar
• Dai H, Zhang L, Cao M, et al. (2011). The role of polymorphisms in circadian pathway genes in breast tumorigenesis. Breast Cancer Res Treat. 127:531–40
   PubMed Web of Science ®Google Scholar
• Davis S, Mirick DK, Stevens RG. (2001). Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 93:1557–62
   PubMed Web of Science ®Google Scholar
• Deming SL, Lu W, Beeghly-Fadiel A, et al. (2012). Melatonin pathway genes and breast cancer risk among Chinese women. Breast Cancer Res Treat. 132:693–9
   PubMed Web of Science ®Google Scholar
• Erren TC, Morfeld P. (2014). Computing chronodisruption: How to avoid potential chronobiological errors in epidemiological studies of shift work and cancer. Chronobiol Int. 31:589–99
   PubMed Web of Science ®Google Scholar
• Fritschi L, Erren TC, Glass DC, et al. (2013). The association between different night shiftwork factors and breast cancer: A case-control study. Br J Cancer. 109:2472–80
   PubMed Web of Science ®Google Scholar
• Fritschi L, Glass DC, Heyworth JS, et al. (2011). Hypotheses for mechanisms linking shiftwork and cancer. Med Hypotheses. 77:430–6
   PubMed Web of Science ®Google Scholar
• Fu L, Lee CC. (2003). The circadian clock: Pacemaker and tumour suppressor. Nat Rev Cancer. 3:350–61
   PubMed Web of Science ®Google Scholar
• Gachon F, Nagoshi E, Brown SA, et al. (2004). The mammalian circadian timing system: From gene expression to physiology. Chromosoma. 113:103–12
   PubMed Web of Science ®Google Scholar
• Garcia-Closas M, Couch FJ, Lindstrom S, et al. (2013). Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet. 45:392–8, 398e1–2
   PubMed Web of Science ®Google Scholar
• Girschik J, Heyworth J, Fritschi L. (2013). Self-reported sleep duration, sleep quality, and breast cancer risk in a population-based case-control study. Am J Epidemiol. 177:316–27
   PubMed Web of Science ®Google Scholar
• Grundy A, Richardson H, Burstyn I, et al. (2013a). Increased risk of breast cancer associated with long-term shift work in Canada. Occup Environ Med. 70:831–8
   PubMed Web of Science ®Google Scholar
• Grundy A, Schuetz JM, Lai AS, et al. (2013b). Shift work, circadian gene variants and risk of breast cancer. Cancer Epidemiol. 37:606–12
   PubMed Web of Science ®Google Scholar
• Hansen J, Lassen CF. (2012). Nested case-control study of night shift work and breast cancer risk among women in the Danish military. Occup Environ Med. 69:551–6
   PubMed Web of Science ®Google Scholar
• Hansen J, Stevens RG. (2012). Case-control study of shift-work and breast cancer risk in Danish nurses: Impact of shift systems. Eur J Cancer. 48:1722–9
   PubMed Web of Science ®Google Scholar
• Hill SM, Blask DE, Xiang S, et al. (2011). Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer. J Mammary Gland Biol Neoplasia. 16:235–45
   PubMed Web of Science ®Google Scholar
• Hoffman AE, Zheng T, Yi C, et al. (2010). The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling. Cancer Prev Res (Phila). 3:539–48
   PubMed Web of Science ®Google Scholar
• Ijaz S, Verbeek J, Seidler A, et al. (2013a). Night-shift work and breast cancer – A systematic review and meta-analysis. Scand J Work Environ Health. 39:431–47
   PubMed Web of Science ®Google Scholar
• Ijaz S, Verbeek J, Seidler A, et al. (2013b). Response to letter to the editor, re: Ijaz S, et al. “Night-shift work and breast cancer – a systematic review and meta-analysis". Scand J Work Environ Health. 39:633–4
   PubMed Web of Science ®Google Scholar
• Jia Y, Lu Y, Wu K, et al. (2013). Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studies. Cancer Epidemiol. 37:197–206
   PubMed Web of Science ®Google Scholar
• Kamdar BB, Tergas AI, Mateen FJ, et al. (2013). Night-shift work and risk of breast cancer: A systematic review and meta-analysis. Breast Cancer Res Treat. 138:291–301
   PubMed Web of Science ®Google Scholar
• Kelleher FC, Rao A, Maguire A. (2014). Circadian molecular clocks and cancer. Cancer Lett. 342:9–18
   PubMed Web of Science ®Google Scholar
• Knutsson A, Alfredsson L, Karlsson B, et al. (2013). Breast cancer among shift workers: Results of the WOLF longitudinal cohort study. Scand J Work Environ Health. 39:170–7
   PubMed Web of Science ®Google Scholar
• Kropp S, Terboven T, Hedicke J, et al. (2007). Good agreement between physician and self-reported hormone therapy data in a case-control study. J Clin Epidemiol. 60:1280–7
   PubMed Web of Science ®Google Scholar
• Lie JS, Kjuus H, Zienolddiny S, et al. (2011). Night work and breast cancer risk among Norwegian nurses: Assessment by different exposure metrics. Am J Epidemiol. 173:1272–9
   PubMed Web of Science ®Google Scholar
• Lie JS, Kjuus H, Zienolddiny S, et al. (2013). Breast cancer among nurses: Is the intensity of night work related to hormone receptor status? Am J Epidemiol. 178:110–17
   PubMed Web of Science ®Google Scholar
• Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M. (2010). Genetic susceptibility to breast cancer. Mol Oncol. 4:174–91
   PubMed Web of Science ®Google Scholar
• Maxwell KN, Nathanson KL. (2013). Common breast cancer risk variants in the post-COGS era: A comprehensive review. Breast Cancer Res. 15:212
   PubMed Web of Science ®Google Scholar
• Mediavilla MD, Sanchez-Barcelo EJ, Tan DX, et al. (2010). Basic mechanisms involved in the anti-cancer effects of melatonin. Curr Med Chem. 17:4462–81
   PubMed Web of Science ®Google Scholar
• Menegaux F, Truong T, Anger A, et al. (2013). Night work and breast cancer: A population-based case-control study in France (the CECILE study). Int J Cancer. 132:924–31
   PubMed Web of Science ®Google Scholar
• Michailidou K, Hall P, Gonzalez-Neira A, et al. (2013). Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 45:353–61, 361e1–2
   PubMed Web of Science ®Google Scholar
• Monsees GM, Kraft P, Hankinson SE, et al. (2012). Circadian genes and breast cancer susceptibility in rotating shift workers. Int J Cancer. 131:2547–52
   PubMed Web of Science ®Google Scholar
• Nickels S, Truong T, Hein R, et al. (2013). Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet. 9:e1003284
   PubMed Web of Science ®Google Scholar
• Pesch B, Harth V, Rabstein S, et al. (2010). Night work and breast cancer – Results from the German GENICA study. Scand J Work Environ Health. 36:134–41
   PubMed Web of Science ®Google Scholar
• Pesch B, Ko Y, Brauch H, et al. (2005). Factors modifying the association between hormone-replacement therapy and breast cancer risk. Eur J Epidemiol. 20:699–711
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911–29
   PubMed Web of Science ®Google Scholar
• Pronk A, Ji B, Shu X, et al. (2010). Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol. 171:953–9
   PubMed Web of Science ®Google Scholar
• Rabstein S, Harth V, Pesch B, et al. (2013). Night work and breast cancer estrogen receptor status – results from the German GENICA study. Scand J Work Environ Health. 39:448–55
   PubMed Web of Science ®Google Scholar
• Reppert SM, Godson C, Mahle CD, et al. (1995). Molecular characterization of a second melatonin receptor expressed in human retina and brain: The Mel1b melatonin receptor. Proc Natl Acad Sci U.S.A. 92:8734–8
   PubMed Web of Science ®Google Scholar
• Schernhammer ES, Hankinson SE. (2009). Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort. Cancer Epidemiol Biomarkers Prev. 18:74–9
   PubMed Web of Science ®Google Scholar
• Schoeps A, Rudolph A, Seibold P, et al. (2014). Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions. Genet Epidemiol. 38:84–93
   PubMed Web of Science ®Google Scholar
• Simonneaux V, Ribelayga C. (2003). Generation of the melatonin endocrine message in mammals: A review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev. 55:325–95
   PubMed Web of Science ®Google Scholar
• Soria V, Martínez-Amorós E, Escaramís G, et al. (2010). Resequencing and association analysis of arylalkylamine N-acetyltransferase (AANAT) gene and its contribution to major depression susceptibility. J Pineal Res. 49:35–44
   PubMed Web of Science ®Google Scholar
• Stevens RG. (2005). Circadian disruption and breast cancer: From melatonin to clock genes. Epidemiology. 16:254–8
   PubMed Web of Science ®Google Scholar
• Stevens RG. (2009). Light-at-night, circadian disruption and breast cancer: Assessment of existing evidence. Int J Epidemiol. 38:963–70
   PubMed Web of Science ®Google Scholar
• Stevens RG, Hansen J, Costa G, et al. (2011). Considerations of circadian impact for defining ‘shift work' in cancer studies: IARC Working Group Report. Occup Environ Med. 68:154–62
   PubMed Web of Science ®Google Scholar
• Stevens RG, Hansen J. (2013). Letter to the editor, re: Night-shift work and risk of breast cancer (Kamdar et al., doi:10.1007/s10549-013-2433-1). Breast Cancer Res Treat. 139:291–4
   PubMedGoogle Scholar
• Stevens RG, Hansen J, Schernhammer ES, Davis S. (2013). Response to Ijaz S, et al. “Night-shift work and breast cancer – A systematic review and meta-analysis”. Scand J Work Environ Health. 39:631–2
   PubMed Web of Science ®Google Scholar
• Straif K, Baan R, Grosse Y, et al. (2007). Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 8:1065–6
   PubMed Web of Science ®Google Scholar
• Takahashi JS, Hong H, Ko CH, McDearmon EL. (2008). The genetics of mammalian circadian order and disorder: Implications for physiology and disease. Nat Rev Genet. 9:764–75
   PubMed Web of Science ®Google Scholar
• Truong T, Liquet B, Menegaux F, et al. (2014). Breast cancer risk, nightwork, and circadian clock gene polymorphisms. Endocr Relat Cancer. 21:629–38
   PubMed Web of Science ®Google Scholar
• Wakefield J. (2007). A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am J Hum Genet. 81:208–27
   PubMed Web of Science ®Google Scholar
• Wang F, Yeung KL, Chan WC, et al. (2013). A meta-analysis on dose-response relationship between night shift work and the risk of breast cancer. Ann Oncol. 24:2724–32
   PubMed Web of Science ®Google Scholar
• Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL. (2007). Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. Neoplasia. 9:797–800
   PubMed Web of Science ®Google Scholar
• Xiang S, Coffelt SB, Mao L, et al. (2008). Period-2: A tumor suppressor gene in breast cancer. J Circadian Rhythms. 6:4
   PubMedGoogle Scholar
• Zhang C, Bao W, Rong Y, et al. (2013). Genetic variants and the risk of gestational diabetes mellitus: A systematic review. Hum Reprod Update. 19:376–90
   PubMed Web of Science ®Google Scholar
• Zhu Y, Stevens RG, Hoffman AE, Tjonneland A, et al. (2011). Epigenetic impact of long-term shiftwork: Pilot evidence from circadian genes and whole-genome methylation analysis. Chronobiol Int. 28:852–61
   PubMed Web of Science ®Google Scholar
• Zienolddiny S, Haugen A, Lie JS, et al. (2013). Analysis of polymorphisms in the circadian-related genes and breast cancer risk in Norwegian nurses working night shifts. Breast Cancer Res. 15:R53
   PubMed Web of Science ®Google Scholar